Your browser doesn't support javascript.
loading
HNRNPH1-related syndromic intellectual disability: Seven additional cases suggestive of a distinct syndromic neurodevelopmental syndrome.
Reichert, Sara C; Li, Rachel; A Turner, Scott; van Jaarsveld, Richard H; Massink, Maarten P G; van den Boogaard, Marie-José H; Del Toro, Mireia; Rodríguez-Palmero, Agustí; Fourcade, Stéphane; Schlüter, Agatha; Planas-Serra, Laura; Pujol, Aurora; Iascone, Maria; Maitz, Silvia; Loong, Lucy; Stewart, Helen; De Franco, Elisa; Ellard, Sian; Frank, Julie; Lewandowski, Raymond.
Affiliation
  • Reichert SC; Department of Human and Molecular Genetics, Clinical Genetics Services, VCU Health, Richmond, Virginia, USA.
  • Li R; Department of Human and Molecular Genetics, Clinical Genetics Services, VCU Health, Richmond, Virginia, USA.
  • A Turner S; Department of Pathology, VCU Health, Richmond, Virginia, USA.
  • van Jaarsveld RH; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Massink MPG; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van den Boogaard MH; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Del Toro M; Pediatric Neurology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERER, Barcelona, Spain.
  • Rodríguez-Palmero A; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Fourcade S; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Schlüter A; Centre for Biomedical Research on Rare Diseases (CIBERER), Institute Carlos III, Madrid, Spain.
  • Planas-Serra L; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Pujol A; Centre for Biomedical Research on Rare Diseases (CIBERER), Institute Carlos III, Madrid, Spain.
  • Iascone M; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Maitz S; Centre for Biomedical Research on Rare Diseases (CIBERER), Institute Carlos III, Madrid, Spain.
  • Loong L; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
  • Stewart H; Centre for Biomedical Research on Rare Diseases (CIBERER), Institute Carlos III, Madrid, Spain.
  • De Franco E; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
  • Ellard S; Laboratorio Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Frank J; Clinical Pediatric Genetic Unit, Pediatric Clinic, Fondazione MBBM, San Gerardo Hospital, Monza, Italy.
  • Lewandowski R; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Clin Genet ; 98(1): 91-98, 2020 07.
Article in En | MEDLINE | ID: mdl-32335897
ABSTRACT
Pathogenic variants in HNRNPH1 were first reported in 2018. The reported individual, a 13 year old boy with a c.616C>T (p.R206W) variant in the HNRNPH1 gene, was noted to have overlapping symptoms with those observed in HNRNPH2-related X-linked intellectual disability, Bain type (MRXSB), specifically intellectual disability and dysmorphic features. While HNRNPH1 variants were initially proposed to represent an autosomal cause of MRXSB, we report an additional seven cases which identify phenotypic differences from MRXSB. Patients with HNRNPH1 pathogenic variants diagnosed via WES were identified using clinical networks and GeneMatcher. Features unique to individuals with HNRNPH1 variants include distinctive dysmorphic facial features; an increased incidence of congenital anomalies including cranial and brain abnormalities, genitourinary malformations, and palate abnormalities; increased incidence of ophthalmologic abnormalities; and a decreased incidence of epilepsy and cardiac defects compared to those with MRXSB. This suggests that pathogenic variants in HNRNPH1 result in a related, but distinct syndromic cause of intellectual disability from MRXSB, which we refer to as HNRNPH1-related syndromic intellectual disability.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Heterogeneous-Nuclear Ribonucleoproteins / Neurodevelopmental Disorders / Intellectual Disability Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: Clin Genet Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Heterogeneous-Nuclear Ribonucleoproteins / Neurodevelopmental Disorders / Intellectual Disability Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: Clin Genet Year: 2020 Type: Article Affiliation country: United States